Katherine S Bowdish - Net Worth and Insider Trading
Katherine S Bowdish Net Worth
The estimated net worth of Katherine S Bowdish is at least $29 Million dollars as of 2025-05-09. Katherine S Bowdish is the Senior Vice President of Alexion Pharmaceuticals Inc and owns about 160,784 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $29 Million. Details can be seen in Katherine S Bowdish's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Katherine S Bowdish has not made any transactions after 2005-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Katherine S Bowdish
Katherine S Bowdish Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katherine S Bowdish owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Katherine S Bowdish’s form 4 insider trades.
Insider Ownership Summary of Katherine S Bowdish
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-15 | Senior Vice President |
Katherine S Bowdish Latest Holdings Summary
Katherine S Bowdish currently owns a total of 1 stock. Katherine S Bowdish owns 160,784 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 15, 2005, with a value of $29 Million.
Latest Holdings of Katherine S Bowdish
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-15 | 160,784 | 182.50 | 29,343,080 |
Holding Weightings of Katherine S Bowdish
Katherine S Bowdish Form 4 Trading Tracker
According to the SEC Form 4 filings, Katherine S Bowdish has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 12,000 shares on June 15, 2005, which brought Katherine S Bowdish around $64,710.
Insider Trading History of Katherine S Bowdish
- 1
Katherine S Bowdish Trading Performance
Katherine S Bowdish Ownership Network
Ownership Network List of Katherine S Bowdish
Ownership Network Relation of Katherine S Bowdish
Katherine S Bowdish Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Katherine S Bowdish is the Senior Vice President of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Katherine S Bowdish Mailing Address
Above is the net worth, insider trading, and ownership report for Katherine S Bowdish. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Katherine S Bowdish's mailing address is: C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
